Lilly Oncology Taking 'Aggressive' Position

Posted: Updated:
(Image of Sue Mahony courtesy of Eli Lilly and Co.) (Image of Sue Mahony courtesy of Eli Lilly and Co.)
INDIANAPOLIS -

The president of Lilly Oncology says the company has a "strong base" of existing and potential treatments to fuel a new strategy for its cancer-fighting pipeline. During an earnings call with investors Tuesday morning, Sue Mahony said the company's oncology unit will be more aggressive, particularly when it comes to potential treatments in earlier stages "that clear a high bar." Officials say Lilly Oncology will sharpen its focus on 10 internal assets, seven of which are currently in the pipeline.

Additionally, Mahony says, Lilly Oncology could continue to connect with other drug makers on partnerships to help drive treatments to market like one signed with Merck & Co. Inc. (NYSE: MRK) earlier this year. The goal, she says, is to boost business development. "Specifically, we will actively pursue assets that combine rationally with our existing products, serve as new potential foundational agents and enable new immuno-oncology breakthroughs," Mahony said. "The good news is that there is a lot of external innovation in oncology, and we intend to be much more active in this space to ensure we have a competitive pipeline going forward."

During a retooling of its business units announced earlier this year, Mahony stayed on as a senior vice president and as president of Lilly Oncology.

Senior Vice President of Global Development and Medical Affairs Levi Garraway, who joined the company in January, says Lilly Oncology is positioned for a "remarkable" opportunity. He says "the vast majority of our internal R&D dollars" will now be focused on the aforementioned seven early-to-mid-stage assets in its oncology pipeline. One potential treatment, Abemaciclib, is awaiting regulatory approval, while several others are in the first, second or third phases of the development process. "We are giving ourselves flexibility to bet more aggressively on portfolio assets with the highest foundational potential," Garraway said, "while de-risking others externally, and importantly, making room to bring external innovation into our oncology portfolio."

During its second quarter earnings report Tuesday, Lilly detailed profit of more than $1 billion, a 35 percent increase from the same period a year earlier, and it revised previous full-year research and development investment expectations to a range of $5 billion to $5.2 billion.

Lilly Oncology President Sue Mahony says the company could continue to connect with other drug makers on partnerships to help drive treatments to market.
  • Perspectives

    • #MeToo, Bullying And What We All Can Do Now

      Indeed, it is an interesting time with so much continuing to come out in Hollywood, the media, other industries, and even our state government related to the sexual harassment of women - women who have remained silent for years. Like those women, I too have been harassed in various ways over the course of my career, even in recent years - and yes, even in top leadership roles. The headline about my departure or the email citing that I was moving on never fully told the real story.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • U.S. Steel 'Renaissance' Spurs $750M Gary Works Investment

      Pittsburgh-based U.S. Steel Corp. (NYSE: X) has announced a $750 million investment in its Gary Works operations. The company says the funds are part of a $2 billion asset revitalization effort that will take place over the next five years. Last year, U.S. Steel detailed plans that involved pumping $35 million into Gary Works, which followed the $23 million first phase of its Hot Strip Mill Restoration Plan. The latest investment, the Indiana Economic Development Corp. says...

    • Salesforce Begins Pathfinder, Reorganization Efforts

      Salesforce.com Inc. (NYSE: CRM) is underway with the first cohort of its Pathfinder Training Program that is part of the tech giant's ongoing Indianapolis growth. The company is partnering with Deloitte to provide business and technical training to Ivy Tech Community College students and Hoosier veterans looking to become Salesforce administrators and developers. The program comes as the company realigns its Marketing Cloud organization. In a statement, Salesforce says it...

    • Hoosier Schools Among 'Best Colleges in America'

      Nearly two dozen Hoosier institutions are included in MONEY magazine's rankings of the Best Colleges in America. More than 700 schools are on the list, which was determined by a number of factors in three categories, including quality of education, affordability, and outcomes.

    • Geovani Bonilla

      IU Health Plans Names VP

      Geovani Bonilla has joined Indiana University Health Plans as vice president of medical operations. He previously served as director of utilization management for Johns Hopkins Healthcare.

    • Fort Wayne Radio Icon Butcher Passes Away

      A fixture in the Fort Wayne radio scene has passed away. Charly Butcher spent more than 30 years in Fort Wayne radio with a successful morning show on WMEE-FM and, most recently, as host of "Fort Wayne's Morning News" on WOWO radio. Butcher was 61. Butcher was part of WMEE's popular "Those Two Guys In The Morning" show with Tony Richards in the 1980s. He joined WOWO in the mid-2000s as host of "Fort Wayne's Morning News With Charly Butcher."